Taipei Exchange - Delayed Quote TWD

Original BioMedicals Co., Ltd. (6483.TWO)

Compare
10.75
-0.25
(-2.27%)
At close: 2:40:08 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Duncan Chen MS Chairman & CTO -- -- --
Dr. Cliff C. Wang Ph.D. Chief Executive Officer and Director -- -- --
Selena Lin Chief Financial Officer -- -- --
Hsiao-Pao Yen Chief Operating Officer and Director -- -- --
Ms. Cecilia Hung Director of Development -- -- --
Dr. Alan Liss Ph.D. Senior Vice President -- -- 1948
Gan Xiao Ping Head of Clinical Research Department -- -- --

Original BioMedicals Co., Ltd.

6F., No.415
Sec. 2, Tiding Blvd. Neihu Dist.
Taipei, 74147
Taiwan
886 2 2658 8599 https://www.i-obm.com/English_Version/index.aspx
Sector: 
Healthcare
Full Time Employees: 
20

Description

Original BioMedicals Co., Ltd., a biotechnology company, chemical entities to solve unmet medical needs in Taiwan. It develops (A01) Radprotect, a pre-clinical product to protects against radiation exposer; (A02) CCM-Ami, which protects normal tissues from the toxic effects of chemotherapeutic agents and ionizing radiation; and ((P01)GLP-1 CCM for the treatment of type 2 diabetes. The company was founded in 2011 and is based in Taipei, Taiwan.

Corporate Governance

Original BioMedicals Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers